Decipher Urologic Cancers
https://events.jspargo.com/Astro22/CUSTOM/corporatemember.png
The Decipher Prostate Genomic Classifier by Veracyte provides prognostic information to help assess each patient’s individual risk of metastasis. Decipher Prostate has been validated in over 75 studies and 60,000 patients as an accurate predictor of metastasis, prostate cancer-specific mortality, and overall survival.